Reta glucagon-like peptide-1 (GLP-1) receptor agonists offer a groundbreaking approach to diabetes management. These innovative therapies operate by mimicking the physiological actions of GLP-1, a hormone secreted by https://bookmarkcork.com/story21499957/reta-glucagon-like-peptide-1-receptor-agonists